Note 6. Biological assets
Palm Rubber TOTAL
EUR Mature Immature Mature Immature
Cost at 1
st
January 2021
55,889,111 13,914,280 56,796,540 23,881,440 150,481,371
Additions (*)
0 4,245,559 0 1,528,379 5,773,938
Disposals
-630,350 -10,740 -1,344,475 -781,103 -2,766,668
Transfer
6,695,221 -5,653,783 5,195,825 -5,150,601 1,086,662
Foreign exchange differences
4,258,855 919,460 4,665,299 1,758,297 11,601,911
Cost at 31
st
December 2021
66,212,837 13,414,776 65,313,189 21,236,412 166,177,214
Accumulated depreciation at 1
st
January 2021
-24,816,102 0 -11,948,675 0 -36,764,777
Depreciation
-2,973,072 0 -2,477,994 0 -5,451,066
Depreciation reversals
489,107 0 750,394 0 1,239,501
Foreign exchange differences
-1,880,985 0 -977,024 0 -2,858,009
Accumulated depreciation at 31
st
December 2021
-29,181,052 0 -14,653,299 0 -43,834,351
Accumulated impairment at 1
st
January 2021
0 0 -216,282 -6,130,481 -6,346,763
Impairment
0 0 -201,978 0 -201,978
Impairment reversal
0 0 0 143,516 143,516
Transfer
0 0 -4,058,669 4,058,669 0
Foreign exchange differences
0 0 -234,155 -297,887 -532,042
Accumulated impairment at 31
st
December 2021
0 0 -4,711,084 -2,226,183 -6,937,267
Net book value at 31
st
December 2021
37,031,785 13,414,776 45,948,806 19,010,229 115,405,596
Cost at 1
st
January 2022
66,212,837 13,414,776 65,313,189 21,236,412 166,177,214
Additions (*)
0 6,199,700 0 1,282,713 7,482,413
Disposals
-952,198 0 -905,821 -1,635,892 -3,493,911
Transfer (***)
7,424,736 -6,997,999 -4,213,088 -1,846,110 -5,632,461
Foreign exchange differences
-2,597,597 -391,853 2,244,270 1,012,781 267,601
Cost at 31
st
December 2022
70,087,778 12,224,624 62,438,550 20,049,904 164,800,856
Accumulated depreciation at 1
st
January 2022
-29,181,051 0 -14,653,300 0 -43,834,351
Depreciation
-3,500,858 0 -2,778,468 0 -6,279,326
Depreciation reversals
794,304 0 592,730 0 1,387,034
Transfer (***)
0 0 65,294 0 65,294
Foreign exchange differences
1,135,500 0 -57,472 0 1,078,028
Accumulated depreciation at 31
st
December 2022
-30,752,105 0 -16,831,216 0 -47,583,321
Accumulated impairment at 1
st
January 2022
0 0 -4,711,086 -2,226,181 -6,937,267
Impairment (**)
0 0 -27,341,960 -182,149 -27,524,109
Impairment reversal
0 0 386,164 1,268,463 1,654,627
Transfer (***)
0 0 4,705,732 1,319,816 6,025,548
Foreign exchange differences
0 0 98,668 -179,948 -81,280
Accumulated impairment at 31
st
December 2022
0 0 -26,862,482 1 -26,862,481
Net book value at 31
st
December 2022
39,335,673 12,224,624 18,744,852 20,049,905 90,355,054
(*) Additions for the period include capitalised costs.
(**) Impairment test on biological assets is disclosed in Note 8.
(***) During previous periods, a positive revaluation for EUR 5.8 million and an impairment for EUR 6.0 million had been booked on biological assets on
the Cambodian segment. Those adjustments having no significant net impact, they were removed in the current year.
Accounting policy regarding current biological assets is disclosed in note 1.12.